Abstract
Development of immunoassays with improved sensitivity, specificity and reliability are of major interest in modern bioanalytical research. We describe the development of a new immunomagnetic fluorescence detection (IM-FD) assay based on specific antigen/antibody interactions and on accumulation of the fluorescence signal on superparamagnetic PE beads in combination with the use of extrinsic fluorescent labels. IM-FD can be easily modified by varying the order of coatings and assay conditions. Depending on the target molecule, antibodies (ABs), entire proteins, or small protein epitopes can be used as capture molecules. The presence of target molecules is detected by fluorescence microscopy using fluorescently labeled secondary or detection antibodies. Here, we demonstrate the potential of the new assay detecting the two tumor markers IGF-I and p53 antibodies in the clinically relevant concentration range. Our data show that the fluorescence-based bead assay exhibits a large dynamic range and a high sensitivity down to the subpicomolar level.
© 2007 SPIE
PDF ArticleMore Like This
Hannes Neuweiler, Silvia Scheffler, and Markus Sauer
WI4 European Conference on Biomedical Optics (ECBO) 2005
Keiko Tawa
CTuW1_02 Conference on Lasers and Electro-Optics/Pacific Rim (CLEO/PR) 2022
Barbara S. Smith, Michael S. Scherman, Aubrey V. Weigel, Kristen L. Jevsevar, Jarvis W. Hill, John S. Spencer, Michael R. McNeil, and Diego Krapf
JWC68 Frontiers in Optics (FiO) 2009